Table 1 Clinical data of HIV-infected patients included in the study

M00

DNA

55

>12

<50

566

>10

TDF + FTC + ETR

M01

Flow

51

3.41

<50

420

3

3TC + ABC + DTG

M02

DNA/Flow

52

27

<50

940

13.58

3TC + ABC + RAL

M03

DNA/Flow

54

16.58

<50

1260

16

TAF + FTC + EVG/c

M04

DNA/Flow

26

4

<50

520

3.67

3TC + ABC + DTG

M05

DNA/Flow

57

27

<50

1400

15.33

TDF + FTC + EVF

M11

Flow

44

13.16

<50

440

11.66

3TC + DRV/c

M15

Flow

48

29.50

<50

380

16.50

3TC + ABC + DTG

M16

Flow

49

30.50

<50

490

2.64

DRV/c + DTG

M17

Flow

47

26.58

<50

820

20.67

3TC + ABC + DTG

M18

Flow

63

19.54

<50

160

18.45

3TC + DTG

M19^a

Flow

51

31.50

<50

200

6.82

DRV/c + DTG

M20^a

DNA/Flow

53

29

<50

1257

1.46

ATV/r + 3TC + ddI

M21

Flow

49

22.79

<50

850

14.66

3TC + ABC + NVP

M22

DNA/Flow

48

26.50

<50

850

2.55

3TC + ABC + DTG

M23^a

DNA/Flow

46

23.46

<50

2850

2.09

3TC + DTG

M25

DNA/Flow

48

17.62

<50

1040

13.87

EVG/c + FTC + TAF

M26

Flow

44

26

<50

511

>15

3TC + ABC + DTG

M27^a

Flow

54

34.39

<50

1380

0.71

DRV/c + RPV

M28

DNA

54

20

<50

750

4.5

3TC + ABC + DTG

P1

RNA

34

9.5

5100–10,400

760

−

UNTREATED

P2

RNA

30

3.42

<50

380

3.16

3TC + ABC + DRV + RTV

P3

RNA

49

4.25

<50

910

4

3TC + ABC + DTG

P4

RNA

49

0.5

<50

280–350

0.25

TAF + FTC + EVG/c

P5^a

RNA

47

24.16

<25

811

4

EFV + FTC + TDF

P6

RNA

51

11.25

<25

215

2

EFV + FTC + TDF + EFV

P7

RNA

46

20.16

<25

828

5.5

DRV